Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|October 13, 2022
Low baseline IFN-γ response could predict hospitalization in COVID-19 patientsMarion Cremoni, Jonathan Allouche, Daisy Graça, et al.
Journal of Epidemiology and Global Health|April 29, 2022
Who Were Hospitalized Deceased Patients from COVID-19 During the First Year of Pandemic? Retrospective Analysis of 1104 Deceased Patients in South of FranceSylvie Arlotto, Kevin Legueult, Alice Blin, et al.
ERJ Open Research|December 8, 2021
Salivary detection of COVID-19: clinical performance of oral sponge sampling for SARS-CoV-2 testingJacques Boutros, Jonathan Benzaquen, Charles Hugo Marquette, et al.
Annals of Translational Medicine|August 5, 2021
A rapid near-patient RT-PCR test for suspected COVID-19: a study of the diagnostic accuracyPaul Hofman, Jacques Boutros, Didier Benchetrit, et al.
Blood|August 23, 2013
Caloric restriction modulates Mcl-1 expression and sensitizes lymphomas to BH3 mimetic in miceOphélie Meynet, Barbara Zunino, Lina Happo, et al.
International Journal of Molecular Sciences|February 25, 2023
Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load SpecimensMarius Ilié, Jonathan Benzaquen, Véronique Hofman, et al.
Blood Advances|March 8, 2021
Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severityJohan Courjon, Océane Dufies, Alexandre Robert, et al.
Pain|March 3, 2022
A follow-up of pain reported by children undergoing outpatient surgery using a smartphone application: AlgoDARPEF multicenter descriptive prospective studyYannick Walrave, Michel Carles, Jean-Noel Evain, et al.
Journal of Travel Medicine|December 20, 2023
Yellow fever vaccine-associated neurologic and viscerotropic disease: a 10-year case series of the French National Reference Center for Arboviruses with clinical and immunological insightsAnne Le Hir, Guillaume A Durand, José Boucraut, et al.
Critical Care Medicine|October 11, 2022
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])Julien Carvelli, Ferhat Meziani, Jean Dellamonica, et al.
Pageof 8